Max Nisen

Health care columnist for Bloomberg Opinion @bopinion. Opinions, food/Philly sports tweets my own. tinyletter.com/Fresser

Categories
N/A
Content Types
N/A
More Information
Location|Languages
Publications
N/A

Published Content

566
bloomberg.com
Article
A Leading HIV Drug Is Way Overpriced in the U.S.
May 16, 2019
bloomberg.com
Article
Valeant's Ugly Past Recedes for Its Successor Bausch
May 6, 2019
bloomberg.com
Article
Alzheimer’s Bust Goes Way Beyond a Setback for Biogen
March 21, 2019
bloomberg.com
Article
J&J Sneezes. Is Something Going Around?
January 22, 2019
bloomberg.com
Article
Roche’s Small Deal Has Big Cancer Promise
January 17, 2019
bloomberg.com
Article
Trump-Inspired Tweets Signal More Drug-Price Pressure
January 9, 2019
bloomberg.com
Article
Bristol-Myers Finds a $74 Billion Biotech Bargain
January 3, 2019
bloomberg.com
Article
Surprise! Drugmakers Are Raising Prices Again
January 2, 2019
bloomberg.com
Article
Pharma's 2019 Prognosis Hinges on These Key Themes
December 27, 2018
bloomberg.com
Article
Glaxo Creates a Consumer Behemoth and a Pharma Question Mark
December 19, 2018
bloomberg.com
Article
Those J&J Baby-Powder Lawsuits Aren't Going Away
December 14, 2018
bloomberg.com
Article
CVS Hears Trump, But Don't Count on Lower Drug Prices
December 5, 2018
bloomberg.com
Article
Walgreens and Humana May Regret a Half-Deal
November 20, 2018
bloomberg.com
Article
Peanut Allergy Remedy Offers Both Hope and Risk
November 19, 2018
bloomberg.com
Article
Lower Drug Prices Get an Assist From a Big Player
November 15, 2018
bloomberg.com
Article
Democrats Can Claim Victory on Health Care
November 7, 2018
bloomberg.com
Article
Eli Lilly's Big Picture Justifies Its Lofty Valuation
November 6, 2018
bloomberg.com
Article
Obamacare Has Managed to Survive, But Can It Thrive?
November 4, 2018
bloomberg.com
Article
AbbVie Best-Seller Humira Shows Its Mortality
November 2, 2018
bloomberg.com
Article
Pfizer's Lingering Hospira Woes Are Troubling
October 30, 2018
bloomberg.com
Article
Trump’s Latest Plan to Slash Drug Prices Has Real Teeth
October 25, 2018
bloomberg.com
Article
This Opioid Bill Is Great, Except For One Big Thing
October 24, 2018
bloomberg.com
Article
Trump's Drug-Ad Price Shaming Won't Fix the Problem
October 15, 2018
bloomberg.com
Article
CVS-Aetna Merger Wins Approval Only to Face Debt Cliff
October 10, 2018
bloomberg.com
Article
Pfizer's Next CEO May Have to Pull Off Some Bold Deals
October 1, 2018
bloomberg.com
Article
Crowded Migraine Market Puts Drugmakers to the Test
September 28, 2018
bloomberg.com
Article
Merck Is Happy With Its CEO. Should Investors Be?
September 26, 2018
bloomberg.com
Article
Fish-Oil Heart Medicine Is Rarest of Drug Breakthroughs
September 24, 2018
bloomberg.com
Article
Elanco's IPO Awakens Animal Spirits
September 20, 2018
bloomberg.com
Article
Congratulations, Cigna! Now Comes the Hard Part.
September 17, 2018
bloomberg.com
Article
The Ghost of Shkreli Still Haunts Drug Prices
September 12, 2018
bloomberg.com
Article
Obamacare Is Poised for a Midterm Booster Shot
September 11, 2018
bloomberg.com
Article
The GOP’s Obamacare Blunder May Strengthen the Law
September 5, 2018
bloomberg.com
Article
CVS’s Drug-Price Plan Lets Pharma Off Too Easy
August 17, 2018
bloomberg.com
Article
Icahn's Retreat May Hand Cigna a Pyrrhic Victory
August 14, 2018
bloomberg.com
Article
Forget Amazon, GM's Move Should Worry Health Insurers
August 7, 2018
bloomberg.com
Article
Carl Icahn Knows It's Never Too Late to Derail a Deal
August 7, 2018
bloomberg.com
Article
Vertex and Alexion Are Schooling Big Biotech
July 26, 2018
bloomberg.com
Article
Eli Lilly's Good Quarter Masks Deeper Risks
July 24, 2018
bloomberg.com
Article
Roche Takes Drug-Price Posturing to New Heights
July 20, 2018
bloomberg.com
Article
AbbVie Has Issues, But It Isn’t the ‘Next Big Drug Short’
July 19, 2018
bloomberg.com
Article
Trump’s Drug-Price Push Butts Into Two Megadeals
July 19, 2018
bloomberg.com
Article
Big Pharma's Metabolism Is Slowing Down
July 16, 2018
bloomberg.com
Article
Beating the Next Superbug Needs a  Big Pharma Payoff
July 14, 2018
bloomberg.com
Article
Trump Said He Got Pfizer to Roll Back Prices. Not Really.
July 11, 2018
bloomberg.com
Article
Merck’s Dangerous Keytruda Success
May 1, 2018
bloomberg.com
Article
Maybe Sanofi Needed Those Expensive Deals After All
April 27, 2018
bloomberg.com
Article
Kanye Can't Save Tesla
April 27, 2018
bloomberg.com
Article
GSK Tries to Fix Pharma on a Budget
April 25, 2018
bloomberg.com
Article
Fly Charts: Wells Fargo's Subprime Smudge and a Chaebol Showdown
April 25, 2018
Authorship Stats
2Sites566Projects287,406Words
About
Max Nisen is a writer who has produced content for businessinsider.com and bloomberg.com
Key Phrases
Editor Responsible, Max Nisen, Mark Gongloff, Drug Prices, Price Hikes, Lung Cancer, Donald Trump, Fda Approval, Health Care, Eli Lilly
© ClearVoice, Inc.